Related Experiment Videos
Nephron-sparing surgery for renal cell carcinoma
1Department of Urology, Cleveland Clinic Foundation, Ohio, USA.
British Journal of Urology
|October 17, 1998
Summary
Nephron-sparing surgery (NSS) is recommended for localized kidney cancer (RCC) patients with compromised kidney function. For small, localized tumors, NSS and radical nephrectomy offer similar cancer cure rates, but long-term kidney function benefits of NSS need more research.
Area of Science:
- Urology
- Nephrology
- Oncology
Background:
- Renal cancer treatment decisions are complex, balancing oncologic outcomes with renal function preservation.
- Nephron-sparing surgery (NSS) is increasingly considered for localized renal cell carcinoma (RCC).
Purpose of the Study:
- To clarify the role of NSS in localized RCC, particularly in patients with compromised renal function or a normal contralateral kidney.
- To compare the efficacy of NSS versus radical nephrectomy for small, localized RCC.
Main Methods:
- Review of recent studies and clinical results concerning NSS and radical nephrectomy for localized RCC.
- Analysis of treatment outcomes focusing on oncologic control and renal function.
Main Results:
- NSS is indicated for localized RCC patients with conditions threatening renal function.
- For small (< 4 cm) unilateral localized RCC, NSS and radical nephrectomy demonstrate comparable curative effectiveness.
- The long-term renal functional advantage of NSS in patients with a normal contralateral kidney warrants further investigation.
Conclusions:
- NSS is a valuable treatment option for select localized RCC patients, especially those with pre-existing renal compromise.
- Surgical approach (NSS vs. radical nephrectomy) for small, localized RCC yields similar oncologic outcomes.
- Further long-term studies are essential to fully elucidate the renal functional benefits of NSS in specific patient populations.